Status:
COMPLETED
Multicenter Study of the Safety and Efficacy of Dermal Filler, Belotero® Soft
Lead Sponsor:
Merz North America, Inc.
Conditions:
Facial Wrinkles
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
This study is to determine the safety and effectiveness of Belotero® Soft compared to active comparator in the correction of mild facial wrinkles, such as nasolabial folds.
Detailed Description
The purpose of the study is to see if Belotero® Soft is safe and effective for correction of mild facial wrinkles, such as nasolabial folds. The second objective of the study is to see if Belotero® So...
Eligibility Criteria
Inclusion
- Subjects must have bilateral facial wrinkles, such as nasolabial folds
Exclusion
- Other nasolabial fold correction within 6 months prior to study entry.
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT00877279
Start Date
November 1 2007
End Date
March 1 2008
Last Update
November 15 2013
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Skin Care & Laser Physicians of Beverly Hills
Los Angeles, California, United States, 90069
2
Maas Clinic
San Francisco, California, United States, 94115
3
Savin Dermatology Center
New Haven, Connecticut, United States, 06511
4
William Coleman, III, MD
Metairie, Louisiana, United States, 70006